Self-management interventions (SMIs) are patient-centered and designed to foster active participation of patients in order to promote well-being and to manage symptoms. Over the past two decades the role of self-management in chronic diseases has gained momentum. Selfmanagement programs are now acknowledged as a key element of quality care. New modes of delivery allow greater access to information and are tailored to address patient needs. This systematic review presents data from clinical studies of self-management over the past decade, summarizes the evidence for program effectiveness and suggests future research directions.
INTRODUCTION
Self-management is the "individual's ability to manage the symptoms, treatment, physical and psychosocial consequences and life style changes inherent in living with a chronic condition" 1 
.
Whilst often instigated by individuals, health professionals, and patient organizations facilitate self-management in partnership with patients. Traditional patient education offers information and technical skills. In contrast, self-management interventions (SMIs) are problem focused, actionoriented and emphasize patient-generated care plans 2 . SMIs include educational, behavioural and cognitive approaches to influence health knowledge, attitudes, beliefs and behaviours and to promote independence, maintain or adjust life roles and address the psychological impact of disease. SMIs address five skills: problem solving, decision-making, resource utilization, collaborative patient/provider relationships and taking action 3 . SMI success depends upon needs assessments identifying specific groups' concerns.
Importance and meaning of self-management for persons with arthritis
Health professionals view SMIs as structured education to develop patients' illness management skills. However, patients view these differently
.
A qualitative study 5 reported arthritis patients viewed SMIs as a way to bring order into their lives, helping them recognize boundaries, mobilize resources, cope with change in self-identity and plan, pace and prioritize.
This study furthers the understanding of SMIs because it identifies and articulates the value of patient-centered approaches and has implications for SMI evaluation in terms of frequency and methodology. SMI evaluation occurs in stages; pre-, intra-and post-intervention, representing a series of snapshots along a continuum and may miss the full impact on the patient. Additionally, differences in outcome data may occur based on who has asked questions and how questions were asked.
History of self-management programs
In the 1980s, Lorig and associates developed the Arthritis Self-Management Program (ASMP) to enhance well-being and quality of life. The original ASMP was not theory based but considered knowledge leads to behaviour change. During program evaluation participants linked program satisfaction with an increased sense of disease control 6 thus Bandura's Social Cognitive Theory 7 was selected as a framework for change. As more SMIs developed, researchers recognized the value of peer-as well as professional-led programs 8 . Lorig's ASMP is the most developed and studied of SMIs and is disseminated by patient organizations across the globe.
Most SMI research evaluates group programs delivered face-to-face. Financial constraints, increasing access and technology have driven mailed and internet program development. The ASMP group (Stanford University, USA) leads the way developing new technologies for selfmanagement. However, many SMIs are still delivered one-to-one by health professionals, the least evaluated delivery mode.
EVIDENCE FOR EFFECTIVENESS OF SELF-MANAGEMENT PROGRAMS
Several systematic reviews of arthritis patient education and SMIs have evaluated studies published up to 2002. Reviews of rheumatoid arthritis (RA) SMIs concluded only those using psychobehavioural approaches led to short-term (up to 9 months) significant improvements in functional disability, but effects are not sustained 9, 10 . Osteoarthritis (OA) and RA study reviews concluded 40% of SMIs led to improved symptoms and disability
11,12
. Effective programs were more common in OA than RA, possibly because OA SMIs more frequently included exercises and recruited larger samples. Programs based on cognitive-behavioural theory (CBT) or social cognitive theory (SCT) yielded better outcomes. Few studies examined effectiveness for 12 months or more. Two systematic reviews of SMI trials in FM concluded that multimodal interventions yielded better outcomes than single mode interventions but improvements were modest and not maintained 13,14 . using key terms of "arthritis," "osteoarthritis, " "rheum$," "fibromyalgia," "self-management," self care " and "patient education." Studies were included if they: were in English; involved randomization; and stated they were SMIs. In total, 30 articles were identified meeting the entry criteria; some were economic evaluations and long-term follow-ups of earlier trials. Studies were excluded if only reporting observational data or long-term follow-up data from previous trials without comparison group data. This review aims to identify whether longer-term (ie >= 12 months) benefits resulted, by diagnosis and if any program or patient characteristics are associated with improvement.
SMIs for individuals with either OA, RA or other arthritic conditions.
Seven studies were identified: two being published within one article and three articles related to one study
15-22
. See Table 1 . Six studies evaluated the ASMP or variations thereof, all including weekly exercise practice (stretch, strength and walking). Two evaluated the ASMP
16,21
; two a mailed, individualized version of the ASMP (SMART: provided over 12-18 months)
15
; one an internet-ASMP
17
; and one a "one-time" mailed ASMP version
22
. The seventh evaluated the individually tailored "I'm Taking Charge of My Arthritis" (ITCA) program provided in individual home visits [18] [19] [20] . All were community or home-based and all (apart from the ITCA study led by health professionals) led by either peer moderators or self-completed. All programs involving contact lasted 6 weeks (in person or internet) and the other two self-completed at a pace to suit participants. Two studies included booster sessions 15, 18, 19 . . Follow-up longer than 12 months occurred in only one study with a control group comparison. At two years, the SMART programme, including booster materials, reduced perceived arthritis severity and doctor visits but by three years, there were no differences
15
.
SMIs for individuals with osteoarthritis
Eight studies were identified
23-30
. Economic analyses were conducted for two studies
31,32
. Table 2 )
See
All studies evaluated pain and function; four also examined health knowledge, behaviors and care use; three measured self-efficacy; but mood and fatigue were infrequently assessed (See Table 5 ). Four studies only reported short-term outcomes (between 4 to 9 months): with three reporting improvements in pain and function
27-29
; and one brief individual SMI reporting no differences
26
. Two studies found no significant differences in outcomes at any follow-up, both having shorter duration interventions of one or five hours
23,26
. Two studies 24,25 included economic analyses. Whilst both had health benefits only one demonstrated cost-effectiveness
32
: a group format being better than individual interventions
27
. Overall, of the four studies evaluating long-term outcomes (ie 12 months or longer) significant, modest effects were found for: pain
24,30
; self-efficacy
25,30
; function 24 and mood
25
. The most effective interventions longer-term were protocolized group SMIs, including six weeks of supervised exercise, using either CBT or SCT approaches led by trained leaders
24,30
SMIs for individuals diagnosed with inflammatory arthritis
Five studies were identified 33-37 ( Table 3) . Four recruited people with RA only and one, pragmatically, RA (50%), early inflammatory arthritis (35%) and psoriatic arthritis (14%)
37
. Three studies recruited people with well-established disease (average 12-15 years) and two early to established disease
34,37
. Studies showed some similarities: all evaluated small group programs (up to 10 participants), were hospital-based and led by health professionals. All except one 34 had control groups, either usual care, information booklets or attention control (an information program). All used ITT analysis. In other respects studies were diverse. Sample sizes ranged from 59 to 218, with only three reporting sample size analyses and recruiting sufficient participants to detect differences
33,36,37
Programme duration varied from 12 -52 hours, over 6 weeks to 9 months, with three including booster sessions (between 3 to 9 months post-programme). Programs also varied in content and delivery. All provided information about the disease and medications. Four explicitly used SCT and/or CBT approaches. Two were led by clinical psychologists using CBT combined with education from multidisciplinary team members using "more traditional didactic approaches" for physical strategies
34,35
. Two described use of leader manuals, staff training in SCT/CBT approaches and applying these throughout programs
33,37
. One study did not explicitly describe its theoretical framework
36
. Only two included regular exercise
36,37
All studies evaluated pain, function and mood. Disease status and self-efficacy were measured in four and fatigue in three studies ( Table 5) . Short-term benefits were found in four studies. Three had longer-term follow-up at 12 months but only two showed benefits 
SMIs for individuals diagnosed with fibromyalgia
Seven studies were identified 38-44 ( . Three studies included at least 10 sessions of supervised exercise spread over 6-10 weeks 40, 42, 43 .
All studies evaluated pain, function, perceived health and mood. Fatigue was measured in seven, self-efficacy and social role/support in four, health behaviours in three and health care use in only two (see Table 5 ). Considering studies using either case-completer or ITT analysis, shortterm benefits were found for 4-6 months in three studies for three or more outcomes 40, 43, 44 . Three had controlled follow-ups between 8-12 months 17,41,43 but only two showed minimal continued benefits: in fitness 41 and self-reported improvement 43 . In summary, no FM studies showed SMIs, with or without exercise, sustained benefits across a range of outcomes for more than 6 months.
SUMMARY OF THE EVIDENCE
Previous reviews have identified psychobehavioural SMIs lead to short-term benefits (ie 6-9 months) but that longer-term benefits are infrequently evaluated and rarely sustained
12,33
. In this updated review we aimed to identify whether recent SMI trials identify any longer-term benefits and whether any program, diagnostic or patient characteristics are associated with improved outcomes.
Of the 30 studies identified, only 14 had follow-ups of 12 months or longer, seven of which (two of the same SMART ASMP) led to sustained benefits in pain and/ or function. . Further evaluation of the timing, delivery (phone, mailing or group) and effectiveness of booster sessions is warranted.
In terms of patient characteristics, there is little research regarding who benefits most from SMIs. The majority of ASMP trials recruited community or online volunteers, who may be more motivated to change. In ASMP studies recruiting from primary or hospital settings (all with OA) there is conflicting evidence, as two studies (with enhanced exercise) were effective 29,30 but a third, was not
25
, supporting an earlier study's findings
47
. Only one ASMP trial has evaluated whether different diagnostic groups fare better, concluding the internet version is more effective in OA, less so in RA and not in FM
17
. Another study 33 reported patients with RA attending without their partner fared better, as they could openly discuss problems without loved ones present.
Additionally, those not benefitting seemed less motivated to participate and change, had poorer heath and more stressful life events
4
. In an FM study, patients with initially higher self-efficacy reported greater improvements
43
. Further research is needed to appropriately target interventions and/or modify SMIs to meet the needs of specific patient groups.
FUTURE DIRECTIONS
To best address the needs of patients with arthritis, we recommend researchers demonstrating positive outcomes from SMIs with sufficient sample sizes, undertake secondary analyses to investigate whether any baseline characteristics may predict better outcomes. We also recommend evaluating longer-term (12 months or more) benefits of SMIs, using protocolised SCT/CBT based programs of sufficient duration, incorporating exercise for 6 sessions or more, should undertake secondary analyses to investigate further whether any patient attributes are associated with better outcomes.
• Examine longer-term (12 months and longer) benefits of SMIs 
